WINTON GROUP Ltd bought a new stake in Centene Corporation (NYSE:CNC – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 64,766 shares of the company’s stock, valued at approximately $2,665,000.
A number of other institutional investors have also modified their holdings of CNC. Addison Advisors LLC increased its holdings in shares of Centene by 455.6% in the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock valued at $26,000 after purchasing an additional 606 shares during the period. SBI Securities Co. Ltd. boosted its stake in shares of Centene by 118.4% in the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock valued at $31,000 after buying an additional 406 shares in the last quarter. Ameriflex Group Inc. boosted its stake in shares of Centene by 152.5% in the third quarter. Ameriflex Group Inc. now owns 1,010 shares of the company’s stock valued at $36,000 after buying an additional 610 shares in the last quarter. GoalVest Advisory LLC purchased a new stake in shares of Centene in the fourth quarter valued at approximately $37,000. Finally, Union Bancaire Privee UBP SA purchased a new stake in shares of Centene in the fourth quarter valued at approximately $37,000. Institutional investors and hedge funds own 93.63% of the company’s stock.
Centene Stock Up 0.0%
CNC opened at $62.35 on Monday. The business’s fifty day moving average is $48.20 and its two-hundred day moving average is $43.36. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.12 and a current ratio of 1.12. The company has a market cap of $30.79 billion, a price-to-earnings ratio of -4.75, a PEG ratio of 0.49 and a beta of 1.09. Centene Corporation has a one year low of $25.08 and a one year high of $63.50.
Analyst Ratings Changes
A number of research firms recently weighed in on CNC. Bank of America lifted their price target on Centene from $72.00 to $74.00 and gave the company a “buy” rating in a research note on Thursday. Mizuho set a $58.00 price target on Centene and gave the company a “neutral” rating in a research note on Wednesday, May 20th. Jefferies Financial Group lifted their price target on Centene from $39.00 to $48.00 and gave the company a “hold” rating in a research note on Wednesday, April 29th. Sanford C. Bernstein lifted their price target on Centene from $48.00 to $68.00 and gave the company an “outperform” rating in a research note on Tuesday, May 5th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Centene in a research note on Monday, April 20th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $59.47.
Read Our Latest Stock Report on Centene
Centene Company Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
See Also
- Five stocks we like better than Centene
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
